Childhood pemphigus vulgaris successfully treated with rituximab.
Loading...
Date
2012-09
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. However, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an 11-year-old boy of childhood pemphigus vulgaris who failed to respond to dexamethasone pulse therapy and was subsequently treated with rituximab and achieved complete remission.
Description
Keywords
Autoimmune bullous diseases, childhood pemphigus vulgaris, rituximab
Citation
Kanwar Amrinder J, Sawatkar Gitesh U, Vinay Keshavamurthy, Hashimoto Takashi. Childhood pemphigus vulgaris successfully treated with rituximab. Indian Journal of Dermatology, Venereology and Leprology. 2012 Sept-Oct; 78(5): 632-634.